Pith. sign in

REVIEW 5 major objections 5 minor 80 references

Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues or Cells and Chromatin or DNA with the Progression of Alzheimers Disease

T0 review · 5 major / 5 minor · reviewed 2026-08-11 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read This paper claims that two photonic measurements can quantify progressive nanoscale structural disorder in Alzheimer's brain tissue, with disorder strength rising from early to severe stages.

desk verdict PWS staging of human AD hippocampus is a credible new result; the DNA-level IPR claim needs a dye control before it can be taken at face value. read the letter →

arxiv 2412.14651 v1 pith:6MNLI5WO submitted 2024-12-19 physics.med-ph physics.bio-phphysics.optics

Fatemah Alharthi , Ishmael Apachigawo , Dhruvil Solanki , Sazzad Khan , Himanshi Singh , Mohammad Moshahid Khan , Prabhakar Pradhan This is my paper · ORCID
classification physics.med-phphysics.bio-phphysics.optics
keywords Alzheimer'sdiseasepartialwavespectroscopyinverseparticipationratiostructuraldisorderDNAdamageconfocalimaginglightscatteringbiomarker
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper tries to establish that partial wave spectroscopy (PWS) on thin brain sections and inverse participation ratio (IPR) analysis of DAPI-stained nuclei can detect and stage the nano-to-submicron structural disorganization that accompanies Alzheimer's disease in human hippocampus tissue. It reports an average PWS disorder strength increase of 6% in low AD, 23% in intermediate AD, and 61% in severe AD relative to controls, a 50% increase in the DNA/chromatin IPR disorder strength for AD, and a 131% increase in DNA double-strand breaks. If these results hold, optical measurements of disorder strength could serve as quantitative biomarkers that track Alzheimer's progression at length scales below ordinary microscopy resolution.

What carries the argument

The load-bearing object is the disorder strength $L_d$, defined as the product of refractive-index variance and correlation length, $L_d=\langle \Delta n^2\rangle l_c$, measured by PWS from the statistics of backscattered light. For DNA/chromatin, the paper constructs a disordered optical lattice from DAPI confocal intensity through the proportionality $n(x,y)=n_0+dn=\rho_{ms0}+\beta\rho_{ms}(x,y)$ with $n\propto M\propto I$, then diagonalizes a tight-binding Hamiltonian with on-site disorder and computes the inverse participation ratio of its eigenfunctions; the average and standard deviation of $\langle \mathrm{IPR}\rangle$ are taken to be proportional to $L_d=\langle\Delta n\rangle l_c$. This machinery converts a fluorescence image into a quantum-localization statistic that quantifies how strongly intensity fluctuations are localized.

What would settle it

Measure the same DAPI-stained AD and control nuclei with an independent mass-density-sensitive method such as electron microscopy or quantitative phase imaging and compare the disorder strengths: if the fluorescence-based IPR rises while the independently measured mass-density disorder does not, the central DNA claim is falsified.

Watch

Extended reading notes

Core claim

The central claim is that Alzheimer's disease produces a measurable, stage-dependent rise in structural disorder at the nano-to-submicron scale in human brain tissue and in the DNA/chromatin inside cell nuclei. Using backscattered light spectra, the authors compute the disorder strength $L_d=\langle \Delta n^2\rangle l_c$ and find it increases monotonically from control through low, intermediate, and severe AD; using confocal fluorescence as a proxy for mass density, they build a disordered optical lattice and compute the inverse participation ratio, finding a 50% higher $L_d$-IPR in AD nuclei. The optical increases are corroborated by elevated amyloid-$\beta$ immunostaining and a 131% rise in $\gamma$-H2A.X-marked DNA double-strand breaks, which the paper interprets as direct evidence that the optical signal tracks molecular damage in the diseased brain.

Load-bearing premise

The DNA/chromatin conclusion depends on DAPI fluorescence intensity being proportional to local molecular mass density ($n\propto M\propto I$) and on micrographs being chosen by the largest intensity change, so if the fluorescence variation is a staining or selection artifact rather than a mass-density change, the IPR increase would not establish DNA structural disorder.

Editorial extensions

If this is right

  • If the reported trends are correct, $L_d$-PWS could serve as a quantitative staging biomarker for Alzheimer's disease in hippocampal tissue, separating low, intermediate, and severe cases from controls.
  • The confocal-IPR pipeline could be applied to DAPI-stained sections from other brain regions or other neurodegenerative diseases without new staining protocols.
  • The co-occurrence of increased optical disorder and increased double-strand breaks suggests that nanoscale structural disorganization and DNA damage are linked features of Alzheimer's progression.
  • Because PWS is sensitive to changes below the optical diffraction limit, these metrics could support earlier detection if validated on larger prospective cohorts.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • A testable extension would be to run the same confocal-IPR analysis on DAPI-stained sections from Parkinson's or frontotemporal dementia cases to see whether the 50% disorder increase is Alzheimer's-specific or a common neurodegeneration signature.
  • If the $n\propto M\propto I$ mapping holds, IPR and PWS could be applied to the same biopsy as independent readouts of chromatin packing versus whole-cell refractive-index disorder, and their disagreement might reveal which cellular compartment drives the signal.
  • The stage dependence of $L_d$-PWS could be converted into a diagnostic threshold, but only after controlling for post-mortem interval, fixation, and sectioning variability in a larger cohort.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

5 major / 5 minor

Summary. The manuscript reports a dual photonics approach for detecting nano- to submicron-scale structural alterations in human hippocampus tissue and in nuclear DNA/chromatin across stages of Alzheimer's disease. Partial wave spectroscopy (PWS) is used to estimate refractive-index fluctuation disorder strength, and a confocal-imaging-based inverse participation ratio (IPR) analysis is applied to DAPI-stained nuclei to infer DNA/chromatin mass-density disorder. The authors report stage-dependent increases in average Ld-PWS of 6% (LAD), 23% (IAD), and 61% (SAD) relative to control, increases in the standard deviation of Ld-PWS of 4.2%, 29%, and 72%, a 50% increase in average Ld-IPR for AD versus control, a 43% increase in its standard deviation, and a 131% increase in DNA double-strand breaks measured by γ-H2A.X ELISA. The AD stages were assigned by pathologists before the optical measurements, and the optical metrics are compared between stage groups and controls.

Significance. If the central claims are correct, the paper would provide a potentially useful optical biomarker pair for AD staging: PWS gives a stage-wise monotonic tissue-level disorder measure, and IPR links nuclear DNA/chromatin disorder to a biochemical DNA-damage endpoint. The study uses human postmortem hippocampus samples, includes independent Aβ and DNA-damage assays, reports large effect sizes with t-test p-values, and builds on an established PWS literature. The main limitations are reproducibility-related: the calibration constant in the PWS formula is not specified, the DAPI-intensity-to-mass-density mapping is asserted rather than validated, the confocal image selection is subjective, and the IPR computation requires unstated parameters. These issues do not necessarily invalidate the tissue-level PWS trend, but they currently prevent the DNA/chromatin-level claim from being accepted as established.

major comments (5)
  1. [§4.2.2, Eq. (1)] The calibration constant B in Eq. (1) is never specified, and no calibration procedure is described. Because Ld-PWS is computed from B, n0, and the measured spectra, the absolute values of the reported disorder strengths cannot be reproduced or compared across laboratories; the authors should state the value of B, how it was determined, and whether it was held fixed across all samples and stages. Without this, the reported 6%, 23%, and 61% increases are not independently verifiable from the manuscript alone.
  2. [§4.3.2, Eq. (3)] The DNA/chromatin-level IPR claim rests entirely on the assumption that DAPI confocal intensity is proportional to local DNA molecular mass density, expressed as n(x,y) = n0 + dn = rho_ms0 + beta*rho_ms and n ∝ M ∝ I. DAPI fluorescence is known to depend on AT base-pair content, DNA conformation, and chromatin accessibility, not simply on total DNA mass; dye penetration, bleaching, and optical path differences in fixed tissue further decouple intensity from mass. The manuscript provides no validation of this mapping, such as a sequence-independent DNA dye, an independent mass-density measurement, or a calibration control. If this assumption fails, the reported 50% increase in Ld-IPR does not establish increased DNA/chromatin structural disorder, so this is a load-bearing point that must be addressed with experimental controls or explicit quantitative justification.
  3. [§4.3.1] The confocal micrograph selection criterion is stated as 'Selection of the micrographs depended on the most change in the stack based on acquisition of the best coverage of the nuclear area.' This is subjective and can bias the IPR comparison upward if AD samples are more likely to have large intensity fluctuations in some z-planes. The authors should specify a predefined, blinded, or fully automated selection rule, or alternatively analyze all z-slices and show that the result is robust to the selection procedure.
  4. [§4.3.2, Eqs. (3)-(6)] The IPR computation depends on the tight-binding hopping amplitude t, the lattice spacing a, the total number of eigenfunctions N = (L/a)^2, and the normalization of dI/I0, but none of these are specified in the methods. Without these parameters, the computation cannot be reproduced, and the reported 50% average increase and 43% standard-deviation increase in Ld-IPR cannot be checked. The authors should state all numerical parameters used in the Hamiltonian and in the IPR averaging, and ideally provide the analysis code or processed data.
  5. [Figures 2, 4, and 6] The sample size is reported only as 'N = 10' in the figure captions, without specifying whether N refers to patients, tissue sections, nuclei, or optical fields. This ambiguity matters because PWS and IPR involve multiple pixels or nuclei per sample, and the effective statistical independence of the measurements determines whether the t-test is valid. The authors should clarify the unit of N, report the number of nuclei/z-stacks analyzed, and provide effect sizes or confidence intervals in addition to p-values.
minor comments (5)
  1. [Abstract and throughout] The text contains typographical inconsistencies, such as 'Alzheimers' in the abstract and inconsistent use of 'Ld' versus 'Ld-PWS' and 'Ld-IPR' across sections; a careful copyedit is needed.
  2. [§2.2 and Figure 4 caption] The length scale is written inconsistently as '165 nm65 nm' and 'L × L (165 nm65 nm)'; it should read '165 nm × 165 nm' or similar.
  3. [§4.3.2, Eq. (1) formatting] Equation (1) is typeset ambiguously: '2𝑘2' should be written as '2k^2' or '2k²' and the denominator should be clearly grouped, preferably as (Δk)², so that the relation between (Δk)² and ln(C(Δk)) is unambiguous.
  4. [Data Availability Statement] The statement 'The data may be available upon request to the corresponding author' is vague; the authors should deposit processed numerical values (mean and standard deviation of Ld-PWS and Ld-IPR per sample) in a public repository or at least provide them in a supplementary table, and should state whether analysis code is available.
  5. [References] Reference 38 is missing author names and page information, and several references are not formatted consistently; these should be corrected for completeness.

Circularity Check

1 steps flagged · score 4.0 of 10

PWS tissue-level result is self-contained; the DNA/chromatin 'disorder' claim relies on a same-group citation chain and a definitional IPR-to-disorder proportionality.

  1. self citation load bearing [Section 4.3.2, Eqs. (5)-(6), supported by refs. [35,76]]
    "It has been reported that the average and the standard deviation of the < IPR> value are correlated to the degree of structural disorder, which can be written as follows: Average〈𝐼𝑃𝑅〉 ∝ 𝐿𝑑−𝐼𝑃𝑅 =< ∆𝑛 >× 𝑙𝑐 (5) std〈𝐼𝑃𝑅〉 ∝ 𝐿𝑑−𝐼𝑃𝑅 =< ∆𝑛 >× 𝑙𝑐 (6)"

    The paper's DNA/chromatin conclusion is that AD shows 'an increase in the degree of structural disorder Ld-IPR,' but Eqs. (5)-(6) set Ld-IPR proportional to the very <IPR> values measured from the DAPI confocal images. The only support offered for this proportionality is the phrase 'It has been reported...' citing refs. [35,76], whose author lists overlap with the present paper (Pradhan, Adhikari, Alharthi, Shukla). No independent calibration of IPR against an orthogonal measure of DNA/chromatin disorder is provided in this manuscript.

full rationale

The paper is mostly a direct optical measurement study. AD stage labels were assigned by pathologists before the optical measurements, and no classifier or parameter was fitted to those labels, so there is no fitted-input-called-prediction circularity. The PWS tissue-level result is self-contained: Ld-PWS is computed from the measured spectral autocorrelation of backscattered light (Eqs. 1-2) and then compared across pathologist-defined groups; that part does not reduce to its inputs. The circularity burden is concentrated in the IPR-based DNA/chromatin claim. The quantity reported as 'structural disorder' (Ld-IPR) is asserted to be proportional to the very <IPR> values computed from the confocal images (Eqs. 5-6), and the authority for that assertion is prior work by the same research group ([35,76]). The DAPI-intensity-to-mass-density mapping (Eq. 3: n ∝ M ∝ I) is a physical assumption that would need independent validation; that is a correctness/validity risk rather than a circular step, so it is not scored here as circularity. Weighing these considerations, the central tissue-level PWS claim has independent empirical content, while the DNA/chromatin-level disorder metric is partly definitional and self-cited. A score of 4 reflects 'some self-citation; central claim still has independent content.'

Assumptions & free parameters 3 free parameters · 6 assumptions · 0 invented entities

The central optical claims rest on the PWS calibration constant B (Eq. 1), the unstated tight-binding hopping amplitude t, and the assumed linear mapping from DAPI intensity to DNA mass density and refractive index (Section 4.3.2). The model assumptions are imported from the authors' prior PWS/IPR papers and are not independently validated here. No new particles, forces, or entities are introduced.

free parameters (3)
  • PWS calibration constant B = not specified
    Appears in Eq. (1) converting backscattered spectral correlations into Ld-PWS; no calibration procedure or value is given in this manuscript.
  • tight-binding hopping amplitude t = not specified
    The Hamiltonian in Section 4.3.2 includes a hopping term t between nearest neighbors; the IPR eigenfunctions and hence Ld-IPR depend on the ratio t/epsilon, but t is never assigned a value or unit.
  • Butterworth filter cutoff frequency = not specified
    A low-pass Butterworth filter is applied 'at a stable frequency' in Section 4.2.2, but the cutoff is not stated; different cutoffs could change the spectral correlation estimates.
assumptions (6)
  • domain assumption Thin tissue is a weakly disordered medium whose backscattered light can be decomposed into independent 1D channels described by mesoscopic light transport theory.
    Invoked in Section 4.2.2 to justify computing Ld-PWS from the reflection intensity and spectral autocorrelation; if multiple scattering or surface effects dominate, Eq. (1) would not measure intracellular disorder.
  • domain assumption DAPI fluorescence intensity is proportional to local DNA molecular mass density, and refractive index is proportional to intensity: n(x,y) = n0 + dn(x,y) = rho_ms0 + beta*rho_ms(x,y), with n proportional M proportional I.
    Section 4.3.2, Eq. (3) and surrounding text; this is the bridge from confocal images to the optical potential in the tight-binding model. It is not validated against independent DNA measurements in this paper.
  • domain assumption Average and standard deviation of IPR are proportional to the disorder strength Ld-IPR = <Delta n> x lc (Eqs. 5 and 6).
    Stated without derivation in Section 4.3.2; the conclusion that higher IPR means more structural disorder rests on this proportionality.
  • domain assumption The Anderson tight-binding model for a two-dimensional optical lattice, with diagonal disorder epsilon_i from local refractive index fluctuations, describes DNA/chromatin structure in cell nuclei.
    Section 4.3.2 constructs the Hamiltonian H = sum epsilon_i |i><i| + t sum <ij> ...; this model choice is imported from prior localization studies and is not independently tested here.
  • domain assumption Pathologist-assigned AD stage categories (LAD, IAD, SAD) from the Michigan Brain Bank are accurate clinical classifications.
    Section 4.1 says samples were 'categorized into different stages by pathologists'; all stage comparisons depend on the reliability of these labels.
  • domain assumption n0 = 1.38 is a valid average refractive index for brain tissue in the PWS calculation.
    Section 4.2.2 says 'n0 (assume 1.38)'; the absolute scale of Ld-PWS depends on this value.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues or Cells and Chromatin or DNA with the Progression of Alzheimers Disease." pith.science (2026). https://pith.science/paper/6MNLI5WO

@misc{pith2026241214651,
  author       = {Pith},
  title        = {Pith review of: Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues or Cells and Chromatin or DNA with the Progression of Alzheimers Disease},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/6MNLI5WO}},
  note         = {Machine review of arXiv:2412.14651}
}
read the original abstract

Understanding alterations in structural disorders in tissue or cells or building blocks, such as DNA or chromatin in the human brain, at the nano to submicron level provides us with efficient biomarkers for Alzheimers detection. Here, we report a dual photonics technique to detect nano- to submicron-scale alterations in brain tissues or cells and DNA or chromatin due to the early to late progression of Alzheimers disease in humans. Using a recently developed mesoscopic light transport technique, fine-focused nano-sensitive partial wave spectroscopy (PWS), we measure the degree of structural disorder in tissues. Furthermore, the chemical-specific inverse participation ratio technique (IPR) was used to measure the DNA or chromatin structural alterations. The results of the PWS and IPR experiments showed a significant increase in the degree of structural disorder at the nano to submicron scale at different stages of AD relative to their controls for both the tissue or cell and DNA cellular levels. The increase in the structural disorder in cells or tissues and DNA or chromatin in the nuclei can be attributed to higher mass density fluctuations in the tissue and DNA or chromatin damage in the nuclei caused by the rearrangements of macromolecules due to the deposition of the amyloid beta protein and damage in DNA or chromatin with the progress of AD.

Figures

Figures reproduced from arXiv: 2412.14651 by the authors.

Figure 1
Figure 1. Ld-PWS of AD human brain tissue representative samples. (a–d) Representative brightfield images of healthy tissue and different stages of AD: control (C), low AD (LAD), intermediate AD (IAD), and severe AD (SAD). (a’–d’) Corresponding Ld images. We performed a statistical analysis of the ensemble average and standard deviation (std) of the Ld-PWS values, as shown. Figure 2a,b represent the avg and std of the Ld-PWS … view at source ↗
Figure 2
Figure 2. PWS analysis of human brain tissue. (a,b) Bar graphs of the average and std of 𝐿𝑑 of the control C and samples of different stages of AD: LAD, IAD, and SAD. The results show an average increase of 6% in LAD, 23% in AD, and 61% in SAD relative to the control C, while there is an increase in the std (Ld-PWS) of 4.2% in LAD, 29% in IAD, and 72% in SAD relative to the control. (Student’s t-test, * p-values < 0.05 for ea… view at source ↗
Figure 3
Figure 3. DNA molecular-specific structural disorder visualized using confocal-IPR imaging of Ld-IPR. (a) DAPI￾stained confocal image of the control human brain tissue; (b) AD human brain tissues that are DAPI stained, targeting DNA/chromatin; (a’,b’) corresponding Ld-IPR images of the control C DAPI-stained brain tissues and AD DAPI￾stained brain tissues, respectively. Bar graphs were employed to analyze the ensemble of IPR … view at source ↗
Figures from the paper (1 more)
Figure 6
Figure 6. Figure 6: Increased DNA double-strand breaks (DDSBs) in the hippocampi of AD patients. The ELISA method was used to assess the protein levels of γ-H2A.X (Ser139) in the hippocampi of AD and non-AD brains. The bar graphs show a net increase of 131% with the progress of AD. Data w…

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

80 extracted references · 74 canonical work pages

  1. [1]

    Microscopic Origin of Light Scattering in Tissue

    Popp, A.K.; Valentine, M.T.; Kaplan, P.D.; Weitz, D.A. Microscopic Origin of Light Scattering in Tissue. Appl. Opt. 2003, 42, 2871–2880. https://doi.org/10.1364/AO.42.002871

    work page doi:10.1364/ao.42.002871 2003

  2. [2]

    Light Scatter Spectroscopy and Imaging of Cellular and Subcellular Events

    Boustany, N.N.; Thakor, N.V . Light Scatter Spectroscopy and Imaging of Cellular and Subcellular Events. In Biomedical Photonics: Handbook; CRC Press: Boca Raton, FL, USA, 2003; p. 16

    work page 2003

  3. [3]

    Light Scattering from Cells: Finite-Difference Time- Domain Simulations and Goniometric Measurements

    Drezek, R.; Dunn, A.; Richards-Kortum, R. Light Scattering from Cells: Finite-Difference Time- Domain Simulations and Goniometric Measurements. Appl. Opt. 1999, 38, 3651–3661. https://doi.org/10.1364/AO.38.003651

    doi:10.1364/ao.38.003651 1999

  4. [4]

    Overview of Single-Cell Elastic Light Scattering Techniques

    Kinnunen, M.; Karmenyan, A. Overview of Single-Cell Elastic Light Scattering Techniques. JBO 2015, 20, 051040. https://doi.org/10.1117/1.JBO.20.5.051040

    work page doi:10.1117/1.jbo.20.5.051040 2015

  5. [5]

    Refractive Index of Biological Tissues: Review, Measurement Techniques, and Applications

    Khan, R.; Gul, B.; Khan, S.; Nisar, H.; Ahmad, I. Refractive Index of Biological Tissues: Review, Measurement Techniques, and Applications. Photodiagnosis Photodyn. Ther. 2021, 33, 102192. https://doi.org/10.1016/j.pdpdt.2021.102192

    arXiv 2021

  6. [6]

    Raman Scattering: From Structural Biology to Medical Applications

    Vlasov, A.V .; Maliar, N.L.; Bazhenov, S.V .; Nikelshparg, E.I.; Brazhe, N.A.; Vlasova, A.D.; Osipov, S.D.; Sudarev, V .V .; Ryzhykau, Y .L.; Bogorodskiy, A.O.; et al. Raman Scattering: From Structural Biology to Medical Applications. Crystals 2020, 10, 38. https://doi.org/10.3390/cryst10010038

    work page doi:10.3390/cryst10010038 2020

  7. [7]

    Cell Refractive Index for Cell Biology and Disease Diagnosis: Past, Present and Future

    Liu, P.Y .; Chin, L.K.; Ser, W.; Chen, H.F.; Hsieh, C.-M.; Lee, C.-H.; Sung, K.-B.; Ayi, T.C.; Yap, P.H.; Liedberg, B.; et al. Cell Refractive Index for Cell Biology and Disease Diagnosis: Past, Present and Future. Lab Chip 2016, 16, 634–644. https://doi.org/10.1039/C5LC01445J

    work page doi:10.1039/c5lc01445j 2016

  8. [8]

    The Fractal Geometry of Life

    Losa, G.A. The Fractal Geometry of Life. Riv. Biol. 2009, 102, 29–59

    work page 2009

Show all 80 references
  1. [9]

    Measuring the Refractive Index of Bovine Corneal Stromal Cells Using Quantitative Phase Imaging

    Gardner, S.J.; White, N.; Albon, J.; Knupp, C.; Kamma-Lorger, C.S.; Meek, K.M. Measuring the Refractive Index of Bovine Corneal Stromal Cells Using Quantitative Phase Imaging. Biophys. J. 2015, 109, 1592–1599. https://doi.org/10.1016/j.bpj.2015.08.046

    2015 doi

  2. [10]

    Light-Scattering Methods for Tissue Diagnosis

    Steelman, Z.A.; Ho, D.S.; Chu, K.K.; Wax, A. Light-Scattering Methods for Tissue Diagnosis. Optica 2019, 6, 479–489. https://doi.org/10.1364/OPTICA.6.000479

    2019 doi

  3. [11]

    Fractal Dimension Analyses to Detect Alzheimer’s and Parkinson’s Diseases Using Their Thin Brain Tissue Samples via Transmission Optical Microscopy

    Apachigawo, I.; Solanki, D.; Tate, R.; Singh, H.; Khan, M.M.; Pradhan, P. Fractal Dimension Analyses to Detect Alzheimer’s and Parkinson’s Diseases Using Their Thin Brain Tissue Samples via Transmission Optical Microscopy. Biophysica 2023, 3, 569–581. https://doi.org/10.3390/b...

    2023 doi

  4. [12]

    Differential Light Scattering: A Physical Method for Identifying Living Bacterial Cells

    Wyatt, P.J. Differential Light Scattering: A Physical Method for Identifying Living Bacterial Cells. Appl. Opt. 1968, 7, 1879–1896. https://doi.org/10.1364/AO.7.001879

    1968 doi

  5. [13]

    Microscopic Imaging and Spectroscopy with Scattered Light

    Boustany, N.N.; Boppart, S.A.; Backman, V. Microscopic Imaging and Spectroscopy with Scattered Light. Annu. Rev. Biomed. Eng. 2010, 12, 285–314. https://doi.org/10.1146/annurev-bioeng-061008- 124811

    2010 doi

  6. [14]

    Partial-Wave Microscopic Spectroscopy Detects Subwavelength Refractive Index Fluctuations: An Application to Cancer Diagnosis

    Subramanian, H.; Pradhan, P.; Liu, Y .; Capoglu, I.R.; Rogers, J.D.; Roy, H.K.; Brand, R.E.; Backman, V. Partial-Wave Microscopic Spectroscopy Detects Subwavelength Refractive Index Fluctuations: An Application to Cancer Diagnosis. Opt. Lett. 2009, 34, 518–520. https://doi.org...

    2009 doi

  7. [15]

    Quantification in Tissue near–Infrared Spectroscopy

    Chance, B.; Cooper, C.E.; Delpy, D.T.; Reynolds, E.O.R.; Delpy, D.T.; Cope, M. Quantification in Tissue near–Infrared Spectroscopy. Philos. Trans. R. Soc. London. Ser. B Biol. Sci. 1997, 352, 649–

    1997

  8. [16]

    Polarized Light Spatial Frequency Domain Imaging for Non-Destructive Quantification of Soft Tissue Fibrous Structures

    Yang, B.; Lesicko, J.; Sharma, M.; Hill, M.; Sacks, M.S.; Tunnell, J.W. Polarized Light Spatial Frequency Domain Imaging for Non-Destructive Quantification of Soft Tissue Fibrous Structures. Biomed. Opt. Express 2015, 6, 1520–1533. https://doi.org/10.1364/BOE.6.001520

    2015 doi

  9. [17]

    Using FDTD to Improve Our Understanding of Partial Wave Spectroscopy for Advancing Ultra Early-Stage Cancer Detection Techniques

    Simpson, J.J.; Capoglu, I.R.; Backman, V. Using FDTD to Improve Our Understanding of Partial Wave Spectroscopy for Advancing Ultra Early-Stage Cancer Detection Techniques. In Proceedings of the 2009 13th International Symposium on Antenna Technology and Applied Electromagnetic...

    2009

  10. [18]

    Multiscale Optical Phase Fluctuations Link Disorder Strength and Fractal Dimension of Cell Structure

    Rancu, A.; Chen, C.X.; Price, H.; Wax, A. Multiscale Optical Phase Fluctuations Link Disorder Strength and Fractal Dimension of Cell Structure. Biophys. J. 2023, 122, 1390–1399. https://doi.org/10.1016/j.bpj.2023.03.005

    2023 doi

  11. [19]

    Qualitative Disorder Measurements from Backscattering Spectra through an Optical Fiber

    Fernández, R.; Marcos-Vidal, A.; Gallego, S.; Beléndez, A.; Desco, M.; Ripoll, J. Qualitative Disorder Measurements from Backscattering Spectra through an Optical Fiber. Biomed. Opt. Express 2020, 11,

    2020

  12. [20]

    Optical Probing of Spatial Structural Abnormalities in Cells/Tissues Due to Cancer, Drug- Effect, and Brain Abnormalities Using Mesoscopic Physics-Based Spectroscopic Techniques

    Adhikari, P. Optical Probing of Spatial Structural Abnormalities in Cells/Tissues Due to Cancer, Drug- Effect, and Brain Abnormalities Using Mesoscopic Physics-Based Spectroscopic Techniques. Ph.D. Thesis, Mississippi State University, Starkville, MS, USA, 2021, https://doi.or...

    2021 doi

  13. [21]

    The Physics of Cancer: The Role of Epigenetics and Chromosome Conformation in Cancer Progression

    Naimark, O.B.; Nikitiuk, A.S.; Baudement, M.-O.; Forné, T.; Lesne, A. The Physics of Cancer: The Role of Epigenetics and Chromosome Conformation in Cancer Progression. AIP Conf. Proc. 2016, 1760, 020051. https://doi.org/10.1063/1.4960270

    2016 doi

  14. [22]

    Reflective Mesoscopic Spectroscopy for Noninvasive Detection of Reflective Index Alternations at Nano-Scale

    Tao, Y .; Ding, Z. Reflective Mesoscopic Spectroscopy for Noninvasive Detection of Reflective Index Alternations at Nano-Scale. J. Phys. Conf. Ser. 2011, 277, 012035. https://doi.org/10.1088/1742- 6596/277/1/012035

    2011 doi

  15. [23]

    Optical Methodology for Detecting Histologically Unapparent Nanoscale Consequences of Genetic Alterations in Biological Cells

    Subramanian, H.; Pradhan, P.; Liu, Y .; Capoglu, I.R.; Li, X.; Rogers, J.D.; Heifetz, A.; Kunte, D.; Roy, H.K.; Taflove, A.; et al. Optical Methodology for Detecting Histologically Unapparent Nanoscale Consequences of Genetic Alterations in Biological Cells. Proc. Natl. Acad. ...

    2008 doi

  16. [24]

    Optical Study of Stress Hormone-Induced Nanoscale Structural Alteration in Brain Using Partial Wave Spectroscopic Microscopy

    Bhandari, S.; Shukla, P.K.; Almabadi, H.M.; Sahay, P.; Rao, R.; Pradhan, P. Optical Study of Stress Hormone-Induced Nanoscale Structural Alteration in Brain Using Partial Wave Spectroscopic Microscopy. J. Biophotonics 2019, 12, e201800002. https://doi.org/10.1002/jbio.201800002

    2019 doi

  17. [25]

    Spatial Light Interference Microscopy: Principle and Applications to Biomedicine

    Chen, X.; Kandel, M.E.; Popescu, G. Spatial Light Interference Microscopy: Principle and Applications to Biomedicine. Adv. Opt. Photon. 2021, 13, 353–425. https://doi.org/10.1364/AOP.417837

    2021 doi

  18. [26]

    Spatial Frequency Metrics for Analysis of Microscopic Images of Musculoskeletal Tissues

    Forouhesh Tehrani, K.; Pendleton, E.G.; Southern, W.M.; Call, J.A.; Mortensen, L.J. Spatial Frequency Metrics for Analysis of Microscopic Images of Musculoskeletal Tissues. Connect. Tissue Res. 2021, 62, 4–14. https://doi.org/10.1080/03008207.2020.1828381

    2021

  19. [27]

    Correlating Colorectal Cancer Risk with Field Carcinogenesis Progression Using Partial Wave Spectroscopic Microscopy

    Gladstein, S.; Damania, D.; Almassalha, L.M.; Smith, L.T.; Gupta, V .; Subramanian, H.; Rex, D.K.; Roy, H.K.; Backman, V. Correlating Colorectal Cancer Risk with Field Carcinogenesis Progression Using Partial Wave Spectroscopic Microscopy. Cancer Med. 2018, 7, 2109–2120. https...

    2018 doi

  20. [28]

    High-Speed Spectral Nanocytology for Early Cancer Screening

    Chandler, J.E.; Subramanian, H.; Maneval, C.D.; White, C.A.; M.d, R.M.L.; Backman, V. High-Speed Spectral Nanocytology for Early Cancer Screening. JBO 2013, 18, 117002. https://doi.org/10.1117/1.JBO.18.11.117002

    2013 doi

  21. [29]

    Nanoscale Markers of Esophageal Field Carcinogenesis: Potential Implications for Esophageal Cancer Screening

    Konda, V .J.; Cherkezyan, L.; Subramanian, H.; Wroblewski, K.; Damania, D.; Becker, V .; Gonzalez, M.H.R.; Koons, A.; Goldberg, M.; Ferguson, M.K.; et al. Nanoscale Markers of Esophageal Field Carcinogenesis: Potential Implications for Esophageal Cancer Screening. Endoscopy 20...

    2013

  22. [30]

    Role of Cytoskeleton in Controlling the Disorder Strength of Cellular Nanoscale Architecture

    Damania, D.; Subramanian, H.; Tiwari, A.K.; Stypula, Y .; Kunte, D.; Pradhan, P.; Roy, H.K.; Backman, V. Role of Cytoskeleton in Controlling the Disorder Strength of Cellular Nanoscale Architecture. Biophys. J. 2010, 99, 989–996. https://doi.org/10.1016/j.bpj.2010.05.023

    2010 doi

  23. [31]

    Label-Free Imaging of the Native, Living Cellular Nanoarchitecture Using Partial-Wave Spectroscopic Microscopy

    Almassalha, L.M.; Bauer, G.M.; Chandler, J.E.; Gladstein, S.; Cherkezyan, L.; Stypula-Cyrus, Y .; Weinberg, S.; Zhang, D.; Thusgaard Ruhoff, P.; Roy, H.K.; et al. Label-Free Imaging of the Native, Living Cellular Nanoarchitecture Using Partial-Wave Spectroscopic Microscopy. Pr...

    2016 doi

  24. [32]

    Identification of Malignancy-Associated Change in Buccal Mucosa with Partial Wave Spectroscopy (PWS): A Potential Biomarker for Lung Cancer Risk

    Hensing, T.A.; Subramanian, H.; Roy, H.K.; Breault, D.; Bogojevic, Z.; Ray, D.; Hasabou, N.; Backman, V. Identification of Malignancy-Associated Change in Buccal Mucosa with Partial Wave Spectroscopy (PWS): A Potential Biomarker for Lung Cancer Risk. JCO 2008, 26, 11045. https...

    2008 doi

  25. [33]

    Measuring Nanoscale Chromatin Heterogeneity with Partial Wave Spectroscopic Microscopy

    Gladstein, S.; Stawarz, A.; Almassalha, L.M.; Cherkezyan, L.; Chandler, J.E.; Zhou, X.; Subramanian, H.; Backman, V. Measuring Nanoscale Chromatin Heterogeneity with Partial Wave Spectroscopic Microscopy. In Cellular Heterogeneity: Methods and Protocols; Barteneva, N.S., V oro...

    2018

  26. [34]

    Quantification of Photonic Localization Properties of Targeted Nuclear Mass Density Variations: Application in Cancer-Stage Detection

    Sahay, P.; Ganju, A.; Almabadi, H.M.; Ghimire, H.M.; Yallapu, M.M.; Skalli, O.; Jaggi, M.; Chauhan, S.C.; Pradhan, P. Quantification of Photonic Localization Properties of Targeted Nuclear Mass Density Variations: Application in Cancer-Stage Detection. J. Biophotonics 2018, 11...

    2018 doi

  27. [35]

    Photonics Probing of Pup Brain Tissue and Molecular-Specific Nuclear Nanostructure Alterations Due to Fetal Alcoholism via Light Scattering/Localization Approaches

    Adhikari, P.; Shukla, P.K.; Alharthi, F.; Bhandari, S.; Meena, A.S.; Rao, R.; Pradhan, P. Photonics Probing of Pup Brain Tissue and Molecular-Specific Nuclear Nanostructure Alterations Due to Fetal Alcoholism via Light Scattering/Localization Approaches. JBO 2022, 27, 076002. ...

    2022 doi

  28. [36]

    Chemical and Immunological Heterogeneity of Fibrillar Amyloid in Plaques of Alzheimer’s Disease and Down’s Syndrome Brains Revealed by Confocal Microscopy

    Schmidt, M.L.; Robinson, K.A.; Lee, V .M.; Trojanowski, J.Q. Chemical and Immunological Heterogeneity of Fibrillar Amyloid in Plaques of Alzheimer’s Disease and Down’s Syndrome Brains Revealed by Confocal Microscopy. Am. J. Pathol. 1995, 147, 503–515

    1995

  29. [37]

    Chronic Stress and Corticosterone Exacerbate Alcohol-Induced Tissue Injury in the Gut-Liver-Brain Axis

    Shukla, P.K.; Meena, A.S.; Dalal, K.; Canelas, C.; Samak, G.; Pierre, J.F.; Rao, R. Chronic Stress and Corticosterone Exacerbate Alcohol-Induced Tissue Injury in the Gut-Liver-Brain Axis. Sci. Rep. 2021, 11, 826. https://doi.org/10.1038/s41598-020-80637-y

    2021 doi

  30. [38]

    Available online: https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.201500298 (accessed on 29 September 2024)

    Colocalization of Cellular Nanostructure Using Confocal Fluorescence and Partial Wave Spectroscopy—Chandler—2017—Journal of Biophotonics—Wiley Online Library. Available online: https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.201500298 (accessed on 29 September 2024)

    2017 doi

  31. [39]

    Nanoscale Imaging of Chromatin with Labeled and Label-Free Super- Resolution Microscopy and Partial-Wave Spectroscopy

    Eshein, A.; Li, Y .; Zhou, X.; Spicer, G.; Nguyen, T.-Q.; Almassalha, L.M.; Chandler, J.E.; Gladstein, S.; Dong, B.; Sun, C.; et al. Nanoscale Imaging of Chromatin with Labeled and Label-Free Super- Resolution Microscopy and Partial-Wave Spectroscopy. In Proceedings of the Bio...

    2018

  32. [40]

    Alzheimer’ s Dement

    2023 Alzheimer’s Disease Facts and Figures. Alzheimer’ s Dement. 2023, 19, 1598–1695. https://doi.org/10.1002/alz.13016

    2023 doi

  33. [41]

    Available online: https://alz- journals.onlinelibrary.wiley.com/doi/epdf/10.1002/alz.12638 (accessed on 26 September 2023)

    2022 Alzheimer’s Disease Facts and Figures. Available online: https://alz- journals.onlinelibrary.wiley.com/doi/epdf/10.1002/alz.12638 (accessed on 26 September 2023)

    2022 doi

  34. [42]

    Clinical Features of Alzheimer’s Disease

    Förstl, H.; Kurz, A. Clinical Features of Alzheimer’s Disease. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249, 288–290. https://doi.org/10.1007/s004060050101

    1999 doi

  35. [43]

    Alzheimer’s Disease

    Querfurth, H.W.; LaFerla, F.M. Alzheimer’s Disease. N. Engl. J. Med. 2010, 362, 329–344. https://doi.org/10.1056/NEJMra0909142

    2010 doi

  36. [44]

    Available online: https://www.mdpi.com/2076- 3425/12/9/1237 (accessed on 28 September 2024)

    Alzheimer’s Disease and Inflammaging. Available online: https://www.mdpi.com/2076- 3425/12/9/1237 (accessed on 28 September 2024)

    2024

  37. [45]

    Is Alzheimer’s Disease an Infectious Neurological Disease? A Review of the Literature

    Uwishema, O.; Mahmoud, A.; Sun, J.; Correia, I.F.S.; Bejjani, N.; Alwan, M.; Nicholas, A.; Oluyemisi, A.; Dost, B. Is Alzheimer’s Disease an Infectious Neurological Disease? A Review of the Literature. Brain Behav. 2022, 12, e2728. https://doi.org/10.1002/brb3.2728

    2022 doi

  38. [46]

    Ranking of Alzheimer’s Disease and Related Dementia among the Leading Causes of Death in the US Varies Depending on NCHS or WHO Definitions

    Tai, S.-Y .; Chi, Y.-C.; Lo, Y.-T.; Chien, Y.-W.; Kwachi, I.; Lu, T.-H. Ranking of Alzheimer’s Disease and Related Dementia among the Leading Causes of Death in the US Varies Depending on NCHS or WHO Definitions. Alzheimer’ s Dement. Diagn. Assess. Dis. Monit. 2023, 15, e12442...

    2023 doi

  39. [47]

    The Metallobiology of Alzheimer’s Disease

    Bush, A.I. The Metallobiology of Alzheimer’s Disease. Trends Neurosci. 2003, 26, 207–214. https://doi.org/10.1016/S0166-2236(03)00067-5

    2003 doi

  40. [48]

    The Neuropathological Diagnosis of Alzheimer’s Disease

    DeTure, M.A.; Dickson, D.W. The Neuropathological Diagnosis of Alzheimer’s Disease. Mol. Neurodegener. 2019, 14, 32. https://doi.org/10.1186/s13024-019-0333-5

    2019 doi

  41. [49]

    Origin of Cancer: Cell Work Is the Key to Understanding Cancer Initiation and Progression

    Hanselmann, R.G.; Welter, C. Origin of Cancer: Cell Work Is the Key to Understanding Cancer Initiation and Progression. Front. Cell Dev. Biol. 2022, 10, 787995. https://doi.org/10.3389/fcell.2022.787995

    2022

  42. [50]

    Biomechanics and Biophysics of Cancer Cells

    Suresh, S. Biomechanics and Biophysics of Cancer Cells. Acta Biomater. 2007, 3, 413–438. https://doi.org/10.1016/j.actbio.2007.04.002

    2007 doi

  43. [51]

    The Structural and Mechanical Complexity of Cell-Growth Control

    Huang, S.; Ingber, D.E. The Structural and Mechanical Complexity of Cell-Growth Control. Nat. Cell Biol. 1999, 1, E131–E138. https://doi.org/10.1038/13043

    1999 doi

  44. [52]

    Photonic Probing of Structural Alterations in DNA Specific Mass Density Fluctuations in Nuclei Due to Total Body Irradiation (TBI) via Confocal Imaging

    Hasan, M.; Shukla, P.K.; Nanda, S.; Adhikari, P.; Rao, R.; Pradhan, P. Photonic Probing of Structural Alterations in DNA Specific Mass Density Fluctuations in Nuclei Due to Total Body Irradiation (TBI) via Confocal Imaging. OSA Contin. 2021, 4, 569–578. https://doi.org/10.1364...

    2021 doi

  45. [53]

    DNA Damage and Its Links to Neurodegeneration

    Madabhushi, R.; Pan, L.; Tsai, L.-H. DNA Damage and Its Links to Neurodegeneration. Neuron 2014, 83, 266–282. https://doi.org/10.1016/j.neuron.2014.06.034

    2014 doi

  46. [54]

    STING Mediates Neurodegeneration and Neuroinflammation in Nigrostriatal α-Synucleinopathy

    Hinkle, J.T.; Patel, J.; Panicker, N.; Karuppagounder, S.S.; Biswas, D.; Belingon, B.; Chen, R.; Brahmachari, S.; Pletnikova, O.; Troncoso, J.C.; et al. STING Mediates Neurodegeneration and Neuroinflammation in Nigrostriatal α-Synucleinopathy. Proc. Natl. Acad. Sci. USA 2022, ...

    2022 doi

  47. [55]

    Early Neuronal Accumulation of DNA Double Strand Breaks in Alzheimer’s Disease

    Shanbhag, N.M.; Evans, M.D.; Mao, W.; Nana, A.L.; Seeley, W.W.; Adame, A.; Rissman, R.A.; Masliah, E.; Mucke, L. Early Neuronal Accumulation of DNA Double Strand Breaks in Alzheimer’s Disease. Acta Neuropathol. Commun. 2019, 7, 77. https://doi.org/10.1186/s40478-019-0723-5

    2019 doi

  48. [56]

    Neurons Burdened by DNA Double-Strand Breaks Incite Microglia Activation through Antiviral-like Signaling in Neurodegeneration

    Welch, G.M.; Boix, C.A.; Schmauch, E.; Davila-Velderrain, J.; Victor, M.B.; Dileep, V .; Bozzelli, P.L.; Su, Q.; Cheng, J.D.; Lee, A.; et al. Neurons Burdened by DNA Double-Strand Breaks Incite Microglia Activation through Antiviral-like Signaling in Neurodegeneration. Sci. Ad...

    2022 doi

  49. [57]

    DNA Double-Strand Break Accumulation in Alzheimer’s Disease: Evidence from Experimental Models and Postmortem Human Brains

    Thadathil, N.; Delotterie, D.F.; Xiao, J.; Hori, R.; McDonald, M.P.; Khan, M.M. DNA Double-Strand Break Accumulation in Alzheimer’s Disease: Evidence from Experimental Models and Postmortem Human Brains. Mol. Neurobiol. 2021, 58, 118–131. https://doi.org/10.1007/s12035-020-02109-8

    2021 doi

  50. [58]

    Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease

    Shukla, P.K.; Delotterie, D.F.; Xiao, J.; Pierre, J.F.; Rao, R.; McDonald, M.P.; Khan, M.M. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease. Cells 2021, 10, 779. https://doi.org/10.3390/cells10040779

    2021 doi

  51. [59]

    DNA Damage and Neurodegenerative Phenotypes in Aged Ciz1 Null Mice

    Khan, M.M.; Xiao, J.; Patel, D.; LeDoux, M.S. DNA Damage and Neurodegenerative Phenotypes in Aged Ciz1 Null Mice. Neurobiol. Aging 2018, 62, 180–190. https://doi.org/10.1016/j.neurobiolaging.2017.10.014

    2018 doi

  52. [60]

    Mesoscopic Light Transport Properties of a Single Biological Cell : Early Detection of Cancer

    Pradhan, P.; Liu, Y .; Kim, Y .; Li, X.; Wali, R.K.; Roy, H.K.; Backman, V. Mesoscopic Light Transport Properties of a Single Biological Cell : Early Detection of Cancer. In APS March Meeting Abstracts, pp. Q1-326. 2006

    2006

  53. [61]

    Partial Wave Spectroscopy Detection of Cancer Stages Using Tissue Microarrays (TMA) Samples

    Adhikari, P.; Alharthi, F.; Pradhan, P. Partial Wave Spectroscopy Detection of Cancer Stages Using Tissue Microarrays (TMA) Samples. In Proceedings of the Frontiers in Optics + Laser Science APS/DLS (2019), Washington, DC, USA, 15 September 2019; paper JW4A.89; Optica Publishi...

    2019

  54. [62]

    Application of Mesoscopic Light Transport Theory to Ultra-Early Detection of Cancer in a Single Biological Cell

    Pradhan, P.; Subramanian, H.; Liu, Y .; Kim, Y .; Roy, H.; Backman, V. Application of Mesoscopic Light Transport Theory to Ultra-Early Detection of Cancer in a Single Biological Cell. In Proceedings of the 2007 APS March Meeting, Denver, CO, USA, 1 March 2007; p. B41.013

    2007

  55. [63]

    Phase Statistics of Light/Photonic Wave Reflected from One-Dimensional Optical Disordered Media and Its Effects on Light Transport Properties

    Pradhan, P. Phase Statistics of Light/Photonic Wave Reflected from One-Dimensional Optical Disordered Media and Its Effects on Light Transport Properties. Photonics 2021, 8, 485. https://doi.org/10.3390/photonics8110485

    2021 doi

  56. [64]

    Localization of Light in Coherently Amplifying Random Media

    Pradhan, P.; Kumar, N. Localization of Light in Coherently Amplifying Random Media. Phys. Rev. B 1994, 50, 9644–9647. https://doi.org/10.1103/PhysRevB.50.9644

    1994 doi

  57. [65]

    Wave Propagation in One-Dimensional Disordered Structures

    Haley, S.B.; Erdös, P. Wave Propagation in One-Dimensional Disordered Structures. Phys. Rev. B 1992, 45, 8572–8584. https://doi.org/10.1103/PhysRevB.45.8572

    1992 doi

  58. [66]

    Single-Cell Partial Wave Spectroscopic Microscopy

    Subramanian, H.; Pradhan, P.; Kunte, D.; Deep, N.; Roy, H.; Backman, V. Single-Cell Partial Wave Spectroscopic Microscopy. In Proceedings of the Biomedical Optics (2008), St. Petersburg, FL, USA, 16 March 2008; paper BTuC5; Optica Publishing Group: Washington, DC, USA, 2008; p. BTuC5

    2008

  59. [67]

    Optical Detection of Buccal Epithelial Nanoarchitectural Alterations in Patients Harboring Lung Cancer: Implications for Screening

    Roy, H.K.; Subramanian, H.; Damania, D.; Hensing, T.A.; Rom, W.N.; Pass, H.I.; Ray, D.; Rogers, J.D.; Bogojevic, A.; Shah, M.; et al. Optical Detection of Buccal Epithelial Nanoarchitectural Alterations in Patients Harboring Lung Cancer: Implications for Screening. Cancer Res....

    2010 doi

  60. [68]

    Optical Detection of the Structural Properties of Tumor Tissue Generated by Xenografting of Drug- Sensitive and Drug-Resistant Cancer Cells Using Partial Wave Spectroscopy (PWS)

    Adhikari, P.; Nagesh, P.K.B.; Alharthi, F.; Chauhan, S.C.; Jaggi, M.; Yallapu, M.M.; Pradhan, P. Optical Detection of the Structural Properties of Tumor Tissue Generated by Xenografting of Drug- Sensitive and Drug-Resistant Cancer Cells Using Partial Wave Spectroscopy (PWS). B...

    2019 doi

  61. [69]

    Localization of Light: Beginning of a New Optics

    Jimenez-Villar, E.; Xavier, M.C.S.; Ramos, J.G.G.S.; Wetter, N.U.; Mestre, V .; Martins, W.S.; Basso, G.F.; Ermakov, V .A.; Marques, F.C.; de Sá, G.F. Localization of Light: Beginning of a New Optics. In Proceedings of the Complex Light and Optical Forces XII, San Francisco, C...

    2018

  62. [70]

    Light Localization Properties of Weakly Disordered Optical Media Using Confocal Microscopy: Application to Cancer Detection

    Sahay, P.; Almabadi, H.M.; Ghimire, H.M.; Skalli, O.; Pradhan, P. Light Localization Properties of Weakly Disordered Optical Media Using Confocal Microscopy: Application to Cancer Detection. Opt. Express 2017, 25, 15428. https://doi.org/10.1364/OE.25.015428

    2017 doi

  63. [71]

    Transport and Anderson Localization in Disordered Two-Dimensional Photonic Lattices

    Schwartz, T.; Bartal, G.; Fishman, S.; Segev, M. Transport and Anderson Localization in Disordered Two-Dimensional Photonic Lattices. Nature 2007, 446, 52–55. https://doi.org/10.1038/nature05623

    2007 doi

  64. [72]

    Quantification of Nanoscale Density Fluctuations Using Electron Microscopy: Light-Localization Properties of Biological Cells

    Pradhan, P.; Damania, D.; Joshi, H.M.; Turzhitsky, V .; Subramanian, H.; Roy, H.K.; Taflove, A.; Dravid, V .P.; Backman, V. Quantification of Nanoscale Density Fluctuations Using Electron Microscopy: Light-Localization Properties of Biological Cells. Appl. Phys. Lett. 2010, 97...

    2010 doi

  65. [73]

    Transverse Localization of Light in the Disordered One- Dimensional Waveguide Arrays in the Linear and Nonlinear Regimes

    Xu, L.; Yin, Y .; Bo, F.; Xu, J.; Zhang, G. Transverse Localization of Light in the Disordered One- Dimensional Waveguide Arrays in the Linear and Nonlinear Regimes. Opt. Commun. 2013, 296, 65–

    2013

  66. [74]

    Light Localization Induced by a Random Imaginary Refractive Index

    Basiri, A.; Bromberg, Y .; Yamilov, A.; Cao, H.; Kottos, T. Light Localization Induced by a Random Imaginary Refractive Index. Phys. Rev. A 2014, 90, 043815. https://doi.org/10.1103/PhysRevA.90.043815

    2014 doi

  67. [75]

    Probing Intracellular Mass Density Fluctuation through Confocal Microscopy: Application in Cancer Diagnostics as a Case Study

    Sahay, P.; Ganju, A.; Ghimire, H.M.; Almabadi, H.; Yallappu, M.M.; Skalli, O.; Jaggi, M.; Chauhan, S.C.; Pradhan, P. Probing Intracellular Mass Density Fluctuation through Confocal Microscopy: Application in Cancer Diagnostics as a Case Study. arXiv 2015, arXiv:1512.08583

    2015 arXiv

  68. [76]

    Quantification of Light Localization Properties to Study the Effect of Probiotic on Chronic Alcoholic Brain Cells via Confocal Imaging

    Adhikari, P.; Shukla, P.K.; Rao, R.; Pradhan, P. Quantification of Light Localization Properties to Study the Effect of Probiotic on Chronic Alcoholic Brain Cells via Confocal Imaging. In Proceedings of the Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissue...

    2021

  69. [77]

    https://doi.org/10.1016/j.optcom.2013.01.056

    2013 doi

  70. [659]

    https://doi.org/10.1098/rstb.1997.0046

    1997

  71. [988]

    https://doi.org/10.1055/s-0033-1344617

    doi

  72. [6038]

    https://doi.org/10.1364/BOE.396013

    doi

Pith tools

Reviewed August 11, 2026 · model on record in the stance chip above.